EXPERIENCE WITH THE USE OF HIGH-DOSE INTERLEUKIN-2 IN THE TREATMENT OF 652 CANCER-PATIENTS

被引:969
作者
ROSENBERG, SA
LOTZE, MT
YANG, JC
AEBERSOLD, PM
LINEHAN, WM
SEIPP, CA
WHITE, DE
机构
关键词
D O I
10.1097/00000658-198910000-00008
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:474 / 485
页数:12
相关论文
共 30 条
[1]  
CAMERON RB, 1988, CANCER RES, V48, P5810
[2]  
DUTCHER JP, 1987, P AN M AM SOC CLIN, V6, P246
[3]  
EISENTHAL A, 1988, CANCER RES, V48, P7140
[4]  
ETTINGHAUSEN SE, 1985, J IMMUNOL, V135, P1488
[5]   IMMUNE INTERVENTIONS IN DISEASE [J].
FAHEY, JL .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :257-274
[6]   TUMOR-LOCALIZATION OF ADOPTIVELY TRANSFERRED IN-111 LABELED TUMOR INFILTRATING LYMPHOCYTES IN PATIENTS WITH METASTATIC MELANOMA [J].
FISHER, B ;
PACKARD, BS ;
READ, EJ ;
CARRASQUILLO, JA ;
CARTER, CS ;
TOPALIAN, SL ;
YANG, JC ;
YOLLES, P ;
LARSON, SM ;
ROSENBERG, SA .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (02) :250-261
[7]  
FISHER RI, 1987, P AN M AM SOC CLIN, V6, P244
[8]   TUMOR NECROSIS FACTOR - STILL A PROMISING AGENT [J].
FREI, E ;
SPRIGGS, D .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (03) :291-294
[9]  
GEMLO BT, 1988, CANCER RES, V48, P5864
[10]  
LAFRENIERE R, 1985, J IMMUNOL, V135, P4273